PEPTONIC medical AB (publ) (XSAT:PMED)
Sweden · Delayed Price · Currency is SEK 0.0600
0.00 (0.00%)
At close: Jan 31, 2024
PEPTONIC medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 26.39 | 26.75 | 27.62 | 38.27 | 46.4 | 32.27 | |
Revenue Growth | 30.43% | -3.13% | -27.83% | -17.54% | 43.82% | 43.82% |
Cost of Revenue | 3.96 | 4.84 | 11.73 | 20.82 | 20.24 | 12.57 |
Gross Profit | 22.43 | 21.92 | 15.89 | 17.44 | 26.17 | 19.69 |
Selling, General & Admin | 33.6 | 35.3 | 56.72 | 52.28 | 56.11 | 65.12 |
Depreciation & Amortization Expenses | 5.75 | 5.76 | 6.69 | 6.27 | 3.49 | 27.06 |
Other Operating Expenses | 0.4 | 0.31 | 11.13 | 0.08 | 0.17 | 1.23 |
Total Operating Expenses | 39.75 | 41.37 | 74.53 | 58.63 | 59.77 | 93.41 |
Operating Income | -21.29 | -19.45 | -58.65 | -41.19 | -33.61 | -73.72 |
Interest Income | - | 0.05 | 0.03 | 0.92 | 2.31 | 0.1 |
Interest Expense | - | -3.09 | -1.41 | -2.32 | -5.56 | -0.07 |
Other Non-Operating Income (Expense) | -1.78 | - | - | - | - | - |
Total Non-Operating Income (Expense) | -1.78 | -3.05 | -1.38 | -1.4 | -3.25 | 0.03 |
Pretax Income | -20.7 | -22.5 | -60.03 | -42.59 | -36.86 | -73.69 |
Net Income | -20.7 | -22.5 | -60.03 | -42.59 | -36.86 | -73.69 |
Net Income to Common | -20.7 | -22.5 | -60.03 | -42.59 | -36.86 | -73.69 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9,661 | 7,530 | 3,600 | 1,175 | 243 | 192 |
Shares Outstanding (Diluted) | 9,661 | 7,530 | 3,600 | 1,175 | 243 | 192 |
Shares Change | 108.59% | 109.16% | 206.37% | 384.12% | 26.67% | 17.63% |
EPS (Basic) | -0.00 | -0.00 | -0.02 | -0.04 | -0.15 | -0.38 |
EPS (Diluted) | -0.00 | -0.00 | -0.02 | -0.04 | -0.15 | -0.38 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -15.4 | -18.19 | -31.94 | -34.45 | -40.22 | -43.36 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.03 | -0.17 | -0.23 |
Gross Margin | 84.99% | 81.93% | 57.52% | 45.58% | 56.39% | 61.03% |
Operating Margin | -80.68% | -72.70% | -212.37% | -107.63% | -72.42% | -228.48% |
Profit Margin | -78.45% | -84.09% | -217.37% | -111.30% | -79.43% | -228.38% |
FCF Margin | -58.38% | -68.01% | -115.66% | -90.04% | -86.66% | -134.40% |
EBITDA | -21.29 | -19.45 | -58.65 | -41.19 | -33.61 | -73.72 |
EBIT | -21.29 | -19.45 | -58.65 | -41.19 | -33.61 | -73.72 |
EBIT Margin | -80.68% | -72.70% | -212.37% | -107.63% | -72.42% | -228.48% |